Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14
about
Identification of receptors for neuromedin U and its role in feedingIdentification and characterization of a second melanin-concentrating hormone receptor, MCH-2RIs urotensin-II the new endothelin?Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1The role of urotensin II in cardiovascular and renal physiology and diseasesThe expression of urotensin II receptor (U2R) is up-regulated by interferon-gammaUrotensin II: ancient hormone with new functions in vertebrate body fluid regulationBiochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytesMurine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide SymposiumIdentification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociceptionThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsUrotensin II in chronic liver disease: in vivo effect on vascular tone.The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosisThe relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticityComparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families.Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets.Cardiostimulant effects of urotensin-II in human heart in vitro.Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsPotential Clinical Implications of the Urotensin II Receptor Antagonists.Comparative distribution and in vitro activities of the urotensin II-related peptides URP1 and URP2 in zebrafish: evidence for their colocalization in spinal cerebrospinal fluid-contacting neurons.Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries.Urotensin-II and the cardiovascular system--the importance of developing modulators.Urotensin II in invertebrates: from structure to function in Aplysia californica.A closer look at the role of urotensin II in the metabolic syndrome.Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?Role of urotensin II in health and disease.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells.Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell lineRGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells.Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.Update on the urotensinergic system: new trends in receptor localization, activation, and drug designUrantide: an ultrapotent urotensin II antagonist peptide in the rat aorta.Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals
P2860
Q22254611-1D1D6C14-C5AB-4E7A-9D0E-6DDBA3FA8133Q24629423-EEB40C13-87F1-4FC1-B78D-6F7053E955E3Q24672927-CA13BCB6-D35B-4BEB-9583-083D5BBF75DAQ24674639-9F87157F-A0B6-463D-A16A-5EE08AFD894DQ24675590-C8E55779-A533-4018-9D34-10677808C392Q28241656-6F8A7AA0-49DC-4AA7-B2F6-884F794F1652Q28250440-5AEBE0EF-56DC-4D6D-BCFC-E0DE7F135F78Q28260943-F389377B-5AF7-4E5F-B8B1-4754A93802A3Q28574132-6840B843-3EE5-4C8E-AB6E-F17F7DC40AF6Q28577654-00C2F7C6-246F-4FC6-8749-75A489F37078Q30486707-B7DE3D75-3E14-421D-A90A-537DEE4565C2Q33378279-EC183BC3-0F4A-470B-AD17-3F8DBF48D8ABQ33599835-49F9FBD3-4CDF-481B-B53B-A8D1AC2F8DF8Q34001118-964C47DA-4962-4A66-9E0D-AAB9BF9562F8Q34066190-444B4A67-2E20-440E-960A-79527E1B73C5Q34260110-92981946-6992-4B72-98FF-DCF647B2702FQ34479147-D52FE049-9872-4409-AE05-C904C428D10FQ34677468-21E0AEAA-86C3-4E93-BA2A-5D8CA28A9974Q34837608-53E859BB-DBEF-4435-AFE4-1FCD80F8CEB4Q35043105-8E8C7B88-269D-4C4E-9312-6331A7A139ABQ35047377-14570040-B922-4B92-9B83-10B05DDFED7DQ35100902-D3775477-65CB-4D17-A72A-1187D6D7B66DQ35128456-3B949368-71D2-4AE7-BA81-DC5129EF2449Q35191049-7FAD1748-761D-4C34-9B76-B3A9B736CE55Q35536658-C308AADA-0E7C-4E42-98F3-88273D32B71AQ35779239-7C5A1585-8094-4F90-BB6E-C9D2C107209EQ36384743-6EE3E060-7D7B-426D-A71E-E05FA876B05BQ36492706-85AB20FE-AA51-4B96-80F4-46E80F8CB40EQ37082781-39ED483A-F50B-489A-85FF-065723047820Q37737495-BA649836-AE52-4CCD-9715-3E639C0584C0Q38196857-FEF53C8D-EE95-4504-8FB0-D0E48B217F42Q38533390-D820CA85-A4EA-40CA-B1B7-5EF0608DFC31Q39018162-E6580C12-E16E-439F-86DE-892FA94E7F98Q39084425-BEC47B1B-80C1-4790-AEBB-5E0F2FB722EEQ40166897-5608C02F-E858-498B-948F-33707885E521Q40735770-3C66954F-FCCD-4D99-8F9D-16075C0D69D7Q41767436-EBB15D40-DE0B-4619-A53A-01D154E26403Q41819007-75A04601-6C1B-43C6-A26D-B370089AC0DAQ42059806-C047688E-B6BD-489B-94E3-C084C788CC92Q42213734-018B9E8B-A6B5-4490-B38F-1E25DBDB9A29
P2860
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Identification of urotensin II ...... protein-coupled receptor GPR14
@ast
Identification of urotensin II ...... protein-coupled receptor GPR14
@en
Identification of urotensin II ...... protein-coupled receptor GPR14
@nl
type
label
Identification of urotensin II ...... protein-coupled receptor GPR14
@ast
Identification of urotensin II ...... protein-coupled receptor GPR14
@en
Identification of urotensin II ...... protein-coupled receptor GPR14
@nl
prefLabel
Identification of urotensin II ...... protein-coupled receptor GPR14
@ast
Identification of urotensin II ...... protein-coupled receptor GPR14
@en
Identification of urotensin II ...... protein-coupled receptor GPR14
@nl
P2093
P356
P1476
Identification of urotensin II ...... protein-coupled receptor GPR14
@en
P2093
A D Howard
C P Austin
C T Caskey
D L Williams
M Davidoff
P356
10.1006/BBRC.1999.1796
P407
P577
1999-12-09T00:00:00Z